feaSibility studies for a phototherapy Mask to treAt dry aGe related Macular degenerAtion (MAGMA)

Polyphotonix正在与伦敦大学学院合作，了解如何将光子治疗传递到眼睛，以治疗称为干龄相关黄斑变性的疾病。在该项目中，将进行可行性研究，以确定有效治疗该疾病所需的剂量，并将研究给药方法。在可行性研究结束时，将设计出一种交付方法，并将制造概念系统的证明，并与包括眼科医生、AMD/失明慈善机构和可能的最终用户在内的重点用户群体进行讨论。计划将在该项目中开展的工作进行到临床试验，以便将该技术推向市场，并获得在NHS或全球医疗保健提供者提供该治疗所需的批准。

Polyphotonix is working with University College London to understand how the delivery of photonic treatments to the eyes can treat the condition known as Dry Age Related Macular Degeneration. In this project a feasibility study will be carried out in order to define the dose required for efficatious treatment of the condition and also a delivery method will be investgated. By the end of the feasibility study, a delivery method, will have been designed and proof of concept systems will have been fabricated and discussed with focus user groups including Opthamologists, AMD/blindness charities and possible end users. It is planned that the work carried out in this project will be carried on to subsequant clinical trials in order to move the technology to market and gain the required approvals for providing this treatment on the NHS or with healthcare providers Worldwide.